Phase I trial: SABR and ipilimumab - Response

Research output: Contribution to journalLetterpeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial: SABR and ipilimumab - Response'. Together they form a unique fingerprint.